Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.

van IJzendoorn DGP, Szuhai K, Briaire-de Bruijn IH, Kostine M, Kuijjer ML, Bovée JVMG.

PLoS Comput Biol. 2019 Feb 20;15(2):e1006826. doi: 10.1371/journal.pcbi.1006826. eCollection 2019 Feb.

2.

Molecular Pathology of Bone Tumors.

Lam SW, van IJzendoorn DGP, Cleton-Jansen AM, Szuhai K, Bovée JVMG.

J Mol Diagn. 2019 Mar;21(2):171-182. doi: 10.1016/j.jmoldx.2018.11.002. Epub 2018 Dec 18. Review.

PMID:
30572118
3.

Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma.

van IJzendoorn DGP, Sleijfer S, Gelderblom H, Eskens FALM, van Leenders GJLH, Szuhai K, Bovée JVMG.

Clin Cancer Res. 2018 Jun 1;24(11):2678-2687. doi: 10.1158/1078-0432.CCR-17-3512. Epub 2018 Mar 6.

4.

Functional analyses of a human vascular tumor FOS variant identify a novel degradation mechanism and a link to tumorigenesis.

van IJzendoorn DGP, Forghany Z, Liebelt F, Vertegaal AC, Jochemsen AG, Bovée JVMG, Szuhai K, Baker DA.

J Biol Chem. 2017 Dec 29;292(52):21282-21290. doi: 10.1074/jbc.C117.815845. Epub 2017 Nov 17.

5.

Vascular Tumors of Bone: The Evolvement of a Classification Based on Molecular Developments.

van IJzendoorn DGP, Bovée JVMG.

Surg Pathol Clin. 2017 Sep;10(3):621-635. doi: 10.1016/j.path.2017.04.003. Review.

PMID:
28797505
6.

PyPanda: a Python package for gene regulatory network reconstruction.

van IJzendoorn DG, Glass K, Quackenbush J, Kuijjer ML.

Bioinformatics. 2016 Nov 1;32(21):3363-3365. Epub 2016 Jul 10.

7.

Fusion events lead to truncation of FOS in epithelioid hemangioma of bone.

van IJzendoorn DG, de Jong D, Romagosa C, Picci P, Benassi MS, Gambarotti M, Daugaard S, van de Sande M, Szuhai K, Bovée JV.

Genes Chromosomes Cancer. 2015 Sep;54(9):565-74. doi: 10.1002/gcc.22269. Epub 2015 Jul 14.

PMID:
26173738

Supplemental Content

Loading ...
Support Center